[Ovarian tissue cryopreservation as a perspective for fertility preservation].
In 2004 the first livebirth after cryopreserved ovarian tissue transplantation has been reported which is a turning point in fertility preservation after anticancer treatment and a result of almost 50 years of research. However transplantation of cryopreserved ovary is still experimental method and further study needs to be done on the risk of cancer cell reimplantation, this method is very promising for cancer patients who wants to preserve fertility after cancer treatment. This is a review of methods used for cryopreserved ovarian tissue.
Jakimiuk
Artur J
AJ
Polish Academy of Sciences Medical Research Center, Warsaw/ II Dept. of Gyn, University School of Medicine, Lublin, and Department of Ob/Gyn, Central Clinical Hospital of Ministry of Interior and Administration, Warsaw, Poland. jakimiuk@yahoo.com
Fritz
Anna
A
D000970:Antineoplastic Agents / Q000009:adverse effects; D015925:Cryopreservation / Q000379:methods*; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007247:Infertility, Female / Q000139:chemically induced / Q000601:surgery*; D009369:Neoplasms / Q000188:drug therapy / Q000532:radiotherapy; D009865:Oocytes; D009926:Organ Preservation / Q000379:methods*; D010053:Ovary / Q000637:transplantation*; D011247:Pregnancy; D011878:Radiotherapy / Q000009:adverse effects; D014182:Transplantation, Autologous
D000970:Antineoplastic Agents